Anatomic Pathology
Case Study using HALO™ and STRATA™: Biomarkers of Anti-Tumor Immune...
- Anatomic Pathology
- Clinical Laboratories
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- General Healthcare News
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Marketing
- Medical Research
- Pathology News
- Science
- Vendor products
- Web/Tech
- Webinars
- Whole slide
Wednesday September 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive. ...
Optra Systems Wins Global Telepathology Enabling Technology Leaders...
OptraSCAN was recently recognized by Frost and Sullivan with a Global Telepathology Enabling Technology Leadership Award. And why shouldn't they be recognized -- I think they are hitting on one of the key market segments that is largely...
Inspirata Acquires Precision Medicine Network, Inc. and the ‘Crossw...
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Data Management
- Device Manufacturers
- Digital Pathology News
- Electronic Medical Records
- File format
- General Healthcare News
- Image Analysis
- Informatics
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Marketing
- Medical Research
- Pathology News
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
“Crosswalk Insight™: Oncology” enhances Inspirata’s Digital Pathology Cockpit by providing access to Genomic Profiles, FDA-Approved Targeted Therapies, Immunotherapies and Clinical Trials to enable pathologists to make more precise...
Last Fall I wrote a couple of posts about the growing disenchantment with 'Pinkification' and 'Pinktober' referencing the all-out blitz during October to go "Pink" for breast bancer awareness and prevention. In one of the pieces I mentioned...
Science, health care and technology conglomerate Danaher Corp. DHR 0.28 % said Tuesday that it would buy molecular-diagnostics company Cepheid Inc. CPHD -0.20 % for $53.00 a share, in its first major acquisition since spinning off a...
Looking for an easier way to build a business case for digital path...
- Anatomic Pathology
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Device Manufacturers
- Digital Pathology News
- Education
- Electronic Medical Records
- General Healthcare News
- Histology
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Marketing
- Pathology News
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
Published August 29, 2016 By Simon Häger, Product Manager Sectra Digital Pathology Solution Although most pathology departments have not yet made the transition to digital, many are actively evaluating the business case. Why? Most...